These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2068462)

  • 21. Aztreonam: review of the clinical experience and potential uses in pediatrics.
    Lebel MH; McCracken GH
    Pediatr Infect Dis J; 1988 May; 7(5):331-9. PubMed ID: 3288947
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.
    Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; Vaneechoutte M; Boelaert J; Schurgers M; Van Landuyt H; Verbeelen D
    Rev Infect Dis; 1991; 13 Suppl 7():S645-7. PubMed ID: 2068475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of aztreonam in serious gram-negative infections.
    Smith G; Bunney RG; Farrell ID; Wood MJ
    J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
    Marco V; Gobernado M; Santos M; Rabinad E
    Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Laboratory and clinical studies on aztreonam in the pediatric field].
    Hosoda T; Masuda M; Miyao M
    Jpn J Antibiot; 1985 Nov; 38(11):3343-8. PubMed ID: 4094067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aztreonam in the treatment of gram-negative bacterial meningitis.
    Lentnek AL; Williams RR
    Rev Infect Dis; 1991; 13 Suppl 7():S586-90. PubMed ID: 2068463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
    Simons WJ; Lee TJ
    Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of aztreonam in the treatment of patients with renal failure.
    Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G
    Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aztreonam: the first monobactam antibiotic.
    Stutman HR
    Pediatr Infect Dis J; 1987 Jun; 6(6):550-5. PubMed ID: 3302907
    [No Abstract]   [Full Text] [Related]  

  • 30. Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infections.
    Swabb EA; Cone CO; Muir JG
    Rev Infect Dis; 1985; 7 Suppl 4():S675-8. PubMed ID: 3909323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overall clinical experience with aztreonam in the treatment of intraabdominal infections.
    Henry SA
    Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of aztreonam in the cystic fibrosis patient.
    Matsen JM; Bosso JA
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S117-9; discussion S128-32. PubMed ID: 2682510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of serious gram-negative infections with aztreonam.
    Greenberg RN; Reilly PM; Luppen KL; McMillian R; Bollinger M; Wolk SM; Darji TB; Noorani AA
    J Infect Dis; 1984 Nov; 150(5):623-30. PubMed ID: 6541672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety profile of aztreonam in clinical trials.
    Newman TJ; Dreslinski GR; Tadros SS
    Rev Infect Dis; 1985; 7 Suppl 4():S648-55. PubMed ID: 2934785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
    Hirotsu T; Akatsuka J; Hoshi Y; Uchiyama H; Fujisawa K; Kobayashi N; Ishidoya N; Ohira M; Takayama J; Ishida Y
    Jpn J Antibiot; 1990 Dec; 43(12):2069-77. PubMed ID: 2086821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy.
    Cook JL
    Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacteriological, pharmacokinetic and clinical studies on aztreonam in the pediatric field. Pediatric Study Group of Aztreonam].
    Fuyii R; Meguro H; Arimasu O; Sunakawa K; Ishizuka Y; Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H
    Jpn J Antibiot; 1985 Nov; 38(11):3195-216. PubMed ID: 3912524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Brogden RN; Heel RC
    Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aztreonam.
    Tunkel AR; Scheld WM
    Infect Control Hosp Epidemiol; 1990 Sep; 11(9):486-94. PubMed ID: 2230052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
    Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
    Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.